Physician profile
Harleen Brar
NPI 1528177565
$5,609.62
in general payments reported to CMS, 2019-2025
26 companies · $619 in 2025
The $619 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,181 · 2020: $926 · 2021: $635 · 2022: $559 · 2023: $814 · 2024: $877 · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,309 · Education: $0.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,308.50 |
| Education | $0.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $950.37 | 2019-2025 | Trelegy Ellipta, Nucala, Benlysta |
| Amgen INC. | $938.02 | 2020-2025 | Tavneos, Krystexxa, Evenity |
| Janssen Biotech, INC. | $856.34 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $849.21 | 2019-2025 | Breztri, Airsupra |
| Pfizer INC. | $349.19 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $305.10 | 2023-2025 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.41 | 2019-2024 | Cyltezo |
| Horizon Therapeutics Plc | $218.32 | 2019-2023 | Krystexxa |
| Genentech USA, INC. | $213.35 | 2019-2020 | |
| Radius Health, INC. | $142.39 | 2019-2025 | Tymlos |
| Genzyme Corporation | $88.94 | 2019-2020 | |
| Abbvie INC. | $73.36 | 2019-2024 | Rinvoq, Humira |
| Fresenius Kabi USA, LLC | $52.50 | 2023-2024 | Idacio |
| Lilly USA, LLC | $46.69 | 2019-2023 | Taltz |
| Novartis Pharmaceuticals Corporation | $37.62 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $29.75 | 2023 | Sunosi |
| Jazz Pharmaceuticals INC. | $27.62 | 2022 | |
| Harmony Biosciences LLC | $24.51 | 2021-2022 | |
| Exact Sciences Corporation | $24.00 | 2023 | Cologuard Collection Kit |
| 3b Medical, INC. | $23.26 | 2025 | Luna |
| Depuy Synthes Sales INC. | $22.64 | 2023 | Orthovisc |
| Ani Pharmaceuticals, INC. | $18.39 | 2025 | Purified Cortrophin Gel |
| Nevro Corp. | $16.66 | 2022 | |
| Alexion Pharmaceuticals, INC. | $13.84 | 2022 | |
| Mylan Specialty L.P. | $13.61 | 2019 | |
| Mallinckrodt Hospital Products INC. | $13.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harleen Brar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.